BioCentury | May 1, 2018
Distillery Therapeutics

Autoimmune disease

...ZP1848), a long-acting GLP-2R agonist, in Phase II to treat SBS. Amunix Operating Inc. and Naia Ltd....
BioCentury | Oct 26, 2015
Financial News

Naia completes venture financing

Naia Ltd. , Greenbrae, Calif. Business: Endocrine/Metabolic, Gastrointestinal Date completed: 2015-10-19 Type: Venture financing Raised: $5.3 million Investors: Pharco Corp. ; The Trout Group; and other undisclosed investors WIR Staff Gastrointestinal...
Items per page:
1 - 2 of 2
BioCentury | May 1, 2018
Distillery Therapeutics

Autoimmune disease

...ZP1848), a long-acting GLP-2R agonist, in Phase II to treat SBS. Amunix Operating Inc. and Naia Ltd....
BioCentury | Oct 26, 2015
Financial News

Naia completes venture financing

Naia Ltd. , Greenbrae, Calif. Business: Endocrine/Metabolic, Gastrointestinal Date completed: 2015-10-19 Type: Venture financing Raised: $5.3 million Investors: Pharco Corp. ; The Trout Group; and other undisclosed investors WIR Staff Gastrointestinal...
Items per page:
1 - 2 of 2